In the final set of experiments, we tested whether administration of amphetamine and atomoxetine, two clinically used medications for the treatment of ADHD (Wigal, 2009), would revert hyperactivity in mutant DAT-N157K rats. The gene discussed is SLC6A3; the disease is attention deficit-hyperactivity disorder.